New Italian Study 'Scalp Cooling in Daily Clinical Practice for Breast Cancer Patients Undergoing Curative Chemotherapy: A Multicenter Interventional Study' published
Teams from the Unit of Medical Oncology, Carpi Civil Hospital, Modena; Oncology Unit, Guastalla Civil Hospital, Reggio Emilia; Oncology Unit, Parma Hospital, Parma have published a paper assessing the effectiveness of scalp cooling in daily clinical practice in three Italian oncology unit, using a PAXMAN system.
The data concluded that scalp cooling provides a reliable chance for breast cancer patients to keep their hair during taxane and/or anthracycline‑based chemotherapy, especially when epirubicin and taxanes are administered. Since 2017, scalp cooling is routinely offered to newly diagnosed breast cancer patients undergoing chemotherapy.
Read the paper for yourself here